Generating ocean…
IDENTITÉ
A clinical-stage company

Identité Therapeutics.
To calm the storm.

For the eye that feels every blink.
Innate immune resolution for the ocular surface.
Scroll
The Disease 01

Dry eye is not dryness.
It's inflammation that will not rest.

Burning.
Grit.
A sandpaper blink.

The Gap 02

All inflammation has TWO arms.
Medicine has answered ONE.

Today's therapies quiet the slower, learned immune response.
The faster native arm rages unchecked.

The Shift 03

We seek not suppression.
But relief.

Inflammation is meant to end.
The body carries an active program for closure.
We aim to restore that program.

The Approach 04

We begin at the mechanism.

Not more tears. Not immunosuppression.
Resolution biology, in the rigor of a clinical program.

The Close 05

Til at last:
A surface at rest.

01 Resolution biology

Not suppression. Restoration of what the surface has forgotten it can do.

02 Established safety

Extensive human safety data. An efficient clinical path.

03 Local by design

Acts where applied. Minimal systemic exposure.

Pipeline

Our path
forward.

Observational

Filamentary Keratitis / Severe Dry Eye

Preclinical

Ophthalmic Safety

IND Enabling

Dry Eye Trial

Bristlecone pine forest at dusk
Our Identity

Rooted in
resilience.

Patient, deep-rooted, unhurried. Durable science, built to last.

For Partners & Investors

Learn more.

Science, data, and pipeline — shared under confidentiality.

Enter the vault →